Cleared Traditional

K162752 - ARTIA Reconstructive Tissue Matrix Perforated

K162752 is an FDA 510(k) clearance for ARTIA Reconstructive Tissue Matrix Perf..., manufactured by Lifecell Corporation. The device is a Class 2 General & Plastic Surgery device with product code FTM cleared through the Traditional 510(k) pathway after a 147-day FDA review.

K162752 · Lifecell Corporation · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2017
Decision
147d
Days
Class 2
Risk

K162752 is an FDA 510(k) clearance for the ARTIA Reconstructive Tissue Matrix Perforated. Classified as Mesh, Surgical (product code FTM), Class II - Special Controls.

Submitted by Lifecell Corporation (Branchburg, US). The FDA issued a Cleared decision on February 24, 2017 after a review of 147 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.3300 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Lifecell Corporation devices

FDA 510(k) Submission Details - K162752

510(k) Number K162752 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2016
Decision Date February 24, 2017
Days to Decision 147 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 115d · This submission: 147d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FTM Device Classification - Class 2, Special Controls

Product Code FTM Mesh, Surgical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - FTM Mesh, Surgical

All 125
Devices cleared under the same product code (FTM) and FDA review panel - the closest regulatory comparables to K162752.
Biodesign Parastomal Hernia Repair Graft
K162934 · Cook Biotech Incorporated · Jul 2017
Biodesign Fistula Plug
K170016 · Cook Biotech Incorporated · Jun 2017
Gentrix Surgical Matrix Thick
K170763 · Acell, Inc. · Jun 2017
Miromatrix Biological Mesh TW
K162570 · Miromatrix Medical, Inc. · Feb 2017
SurgiMend MP Collagen Matrix for Soft Tissue Reconstruction
K162965 · Tei Biosciences, Inc. · Feb 2017
CuraSeal Percutaneous Intraluminal Closure System for Anorectal Fistulas(PICS-AF)
K162388 · Curaseal, Inc. · Feb 2017